• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHC 表达控制系统的结构方面。

Structural aspects of the MHC expression control system.

机构信息

Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR 97239, USA.

Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

Biophys Chem. 2022 May;284:106781. doi: 10.1016/j.bpc.2022.106781. Epub 2022 Feb 15.

DOI:10.1016/j.bpc.2022.106781
PMID:35228036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8941990/
Abstract

The major histocompatibility complex (MHC) spans innate and adaptive immunity by presenting antigenic peptides to CD4 and CD8 T cells. Multiple transcription factors form an enhanceosome complex on the MHC promoter and recruit transcriptional machinery to activate gene transcription. Immune signals such as interferon-γ (IFN-γ) control MHC level by up-regulating components of the enhanceosome complex. As MHC plays crucial roles in immune regulation, alterations in the MHC enhanceosome structure will alter the pace of rapid immune responses at the transcription level and lead to various diseases related to the immune system. In this review, we discuss the current understanding of the MHC enhanceosome, with a focus on the structures of MHC enhanceosome components and the molecular basis of MHC enhanceosome assembly.

摘要

主要组织相容性复合体 (MHC) 通过向 CD4 和 CD8 T 细胞呈递抗原肽来跨越先天和适应性免疫。多个转录因子在 MHC 启动子上形成增强子复合物,并募集转录机制来激活基因转录。干扰素-γ (IFN-γ) 等免疫信号通过上调增强子复合物的组成部分来控制 MHC 水平。由于 MHC 在免疫调节中起着至关重要的作用,因此 MHC 增强子结构的改变将改变转录水平上快速免疫反应的速度,并导致与免疫系统相关的各种疾病。在这篇综述中,我们讨论了对 MHC 增强子的现有理解,重点介绍了 MHC 增强子成分的结构和 MHC 增强子组装的分子基础。

相似文献

1
Structural aspects of the MHC expression control system.MHC 表达控制系统的结构方面。
Biophys Chem. 2022 May;284:106781. doi: 10.1016/j.bpc.2022.106781. Epub 2022 Feb 15.
2
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.卡波西肉瘤相关疱疹病毒潜伏相关核抗原通过与调节因子X复合物结合破坏增强体组装来抑制主要组织相容性复合体II类表达。
J Virol. 2015 May;89(10):5536-56. doi: 10.1128/JVI.03713-14. Epub 2015 Mar 4.
3
Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.组蛋白去乙酰化酶1/mSin3A破坏γ干扰素诱导的CIITA功能以及主要组织相容性复合体II类增强体的形成。
Mol Cell Biol. 2003 May;23(9):3091-102. doi: 10.1128/MCB.23.9.3091-3102.2003.
4
NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.NLRC5通过一个独特的SXY模块专门激活MHC I类及相关基因。
PLoS Genet. 2015 Mar 26;11(3):e1005088. doi: 10.1371/journal.pgen.1005088. eCollection 2015 Mar.
5
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.I 类转录激活物 NLRC5:MHC I 类途径和癌症免疫监视的核心参与者。
Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
6
Expression of MHC II genes.MHC II类基因的表达
Curr Top Microbiol Immunol. 2005;290:147-70. doi: 10.1007/3-540-26363-2_7.
7
Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.CIITA和MHC II类增强体在转录激活中的启动子特异性功能。
EMBO J. 2002 Mar 15;21(6):1379-88. doi: 10.1093/emboj/21.6.1379.
8
Forkhead transcription factor FOXO3a mediates interferon-γ-induced MHC II transcription in macrophages.叉头框转录因子 FOXO3a 介导干扰素-γ诱导的巨噬细胞中 MHC II 的转录。
Immunology. 2019 Dec;158(4):304-313. doi: 10.1111/imm.13116. Epub 2019 Oct 3.
9
Selective Stimulation of Duplicated Atlantic Salmon MHC Pathway Genes by Interferon-Gamma.干扰素-γ对重复大西洋鲑 MHC 途径基因的选择性刺激。
Front Immunol. 2020 Oct 6;11:571650. doi: 10.3389/fimmu.2020.571650. eCollection 2020.
10
CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.CIITA是一种转录共激活因子,它通过与增强体复合物的多种协同相互作用被招募到MHC II类启动子上。
Genes Dev. 2000 May 1;14(9):1156-66.

引用本文的文献

1
Major Histocompatibility Complex Class II Deficiency Beyond Infancy.婴儿期后的主要组织相容性复合体II类缺陷
Case Reports Immunol. 2025 Jul 27;2025:8570051. doi: 10.1155/crii/8570051. eCollection 2025.
2
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.FBXO11 通过泛素依赖性蛋白酶体降解 CIITA 构成 MHC Ⅱ类的主要负调控因子。
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2218955120. doi: 10.1073/pnas.2218955120. Epub 2023 Jun 6.
3
T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac.

本文引用的文献

1
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
2
Structure of the activated ROQ1 resistosome directly recognizing the pathogen effector XopQ.激活的 ROQ1 抵抗体的结构,直接识别病原体效应物 XopQ。
Science. 2020 Dec 4;370(6521). doi: 10.1126/science.abd9993.
3
A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.一名患有MHC II缺陷的中国儿童中的新型RFXANK突变:病例报告及文献综述
COVID-19 康复者和联合载体疫苗 Gam-COVID-Vac 接种者的 T 细胞免疫
Int J Mol Sci. 2023 Jan 18;24(3):1930. doi: 10.3390/ijms24031930.
4
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.潜伏性前列腺癌固有免疫景观的框架。
Cells. 2022 May 5;11(9):1550. doi: 10.3390/cells11091550.
Open Forum Infect Dis. 2020 Jul 24;7(8):ofaa314. doi: 10.1093/ofid/ofaa314. eCollection 2020 Aug.
4
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.MHC Ⅱ类转录激活物 CIITA 诱导细胞抵抗埃博拉病毒和 SARS 样冠状病毒。
Science. 2020 Oct 9;370(6513):241-247. doi: 10.1126/science.abb3753. Epub 2020 Aug 27.
5
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.癌症中MHC I类分子下调:潜在机制及癌症免疫治疗的潜在靶点
Cancers (Basel). 2020 Jul 2;12(7):1760. doi: 10.3390/cancers12071760.
6
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.NEK7 许可激活 NLRP3 炎症小体的结构机制。
Nature. 2019 Jun;570(7761):338-343. doi: 10.1038/s41586-019-1295-z. Epub 2019 Jun 12.
7
Structural basis for specific flagellin recognition by the NLR protein NAIP5.NLR 蛋白 NAIP5 特异性识别鞭毛蛋白的结构基础。
Cell Res. 2018 Jan;28(1):35-47. doi: 10.1038/cr.2017.148. Epub 2017 Nov 28.
8
The structural basis of flagellin detection by NAIP5: A strategy to limit pathogen immune evasion.NAIP5检测鞭毛蛋白的结构基础:一种限制病原体免疫逃逸的策略。
Science. 2017 Nov 17;358(6365):888-893. doi: 10.1126/science.aao1140.
9
NLRC5, a promising new entry in tumor immunology.NLRC5,肿瘤免疫学领域的一颗新星。
J Immunother Cancer. 2016 Jul 19;4:39. doi: 10.1186/s40425-016-0143-z. eCollection 2016.
10
Inflammasomes: mechanism of assembly, regulation and signalling.炎症小体:组装、调控和信号转导机制。
Nat Rev Immunol. 2016 Jul;16(7):407-20. doi: 10.1038/nri.2016.58. Epub 2016 Jun 13.